These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 31956010)
1. Bladder Cancer Stage Development, 2004-2014 in Europe Compared With the United States: Analysis of European Population-based Cancer Registries, the United States SEER Database, and a Large Tertiary Institutional Cohort. Schulz GB; Grimm T; Buchner A; Jokisch F; Kretschmer A; Stief CG; Knüchel R; Kraywinkel K; Karl A Clin Genitourin Cancer; 2020 Jun; 18(3):162-170.e4. PubMed ID: 31956010 [TBL] [Abstract][Full Text] [Related]
2. Development and Optimization of a Bladder Cancer Algorithm Using SEER-Medicare Claims Data. Gore JL; Wright P; Shih V; Chang NN; Noshad S; Rey GG; Wang S; Narayanan S JCO Clin Cancer Inform; 2024 Sep; 8():e2400073. PubMed ID: 39298694 [TBL] [Abstract][Full Text] [Related]
3. Non-bladder cancer mortality in patients with urothelial cancer of the bladder. Scosyrev E; Wu G; Golijanin D; Messing E Urol Oncol; 2013 Jul; 31(5):656-63. PubMed ID: 21550827 [TBL] [Abstract][Full Text] [Related]
4. Incidence, initial management and survival of high-risk non-muscle invasive bladder cancer in Northern France. Saint F; Pasquier D; Villers A; Massa J; Colin P; Vankemmel O; Leroy X; Bonnal JL; Plouvier SD Fr J Urol; 2024 Sep; 34(9):102675. PubMed ID: 38969304 [TBL] [Abstract][Full Text] [Related]
5. Bladder cancer incidence rates and trends in young adults aged 20-39 years. Palumbo C; Pecoraro A; Rosiello G; Luzzago S; Deuker M; Stolzenbach F; Tian Z; Shariat SF; Simeone C; Briganti A; Saad F; Berruti A; Antonelli A; Karakiewicz PI Urol Oncol; 2020 Dec; 38(12):934.e11-934.e19. PubMed ID: 32653412 [TBL] [Abstract][Full Text] [Related]
6. Squamous Cell Carcinoma of the Bladder: A SEER Database Analysis. Abdel-Rahman O Clin Genitourin Cancer; 2017 Jun; 15(3):e463-e468. PubMed ID: 27876505 [TBL] [Abstract][Full Text] [Related]
7. Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006. Nielsen ME; Smith AB; Meyer AM; Kuo TM; Tyree S; Kim WY; Milowsky MI; Pruthi RS; Millikan RC Cancer; 2014 Jan; 120(1):86-95. PubMed ID: 24122346 [TBL] [Abstract][Full Text] [Related]
8. Systematic review of population-based bladder cancer registries: How criteria heterogeneity affects the comparison of incidences. Caballero JM; Gili JM; Pereira JC; Gomáriz A; Castillo C; Martín-Baranera M Cancer Med; 2023 Mar; 12(6):7540-7551. PubMed ID: 36530046 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer. Williams SB; Shan Y; Ray-Zack MD; Hudgins HK; Jazzar U; Tyler DS; Freedland SJ; Swanson TA; Baillargeon JG; Hu JC; Kaul S; Kamat AM; Gore JL; Mehta HB JAMA Surg; 2019 Aug; 154(8):e191629. PubMed ID: 31166593 [TBL] [Abstract][Full Text] [Related]
10. Head and neck squamous cell cancers in the United States are rare and the risk now is higher among white individuals compared with black individuals. Fakhry C; Krapcho M; Eisele DW; D'Souza G Cancer; 2018 May; 124(10):2125-2133. PubMed ID: 29533459 [TBL] [Abstract][Full Text] [Related]
11. Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer. Williams SB; Huo J; Chamie K; Hu JC; Giordano SH; Hoffman KE; Dinney CPN; Kamat AM; Shih YT Eur Urol Focus; 2017 Apr; 3(2-3):258-264. PubMed ID: 28753760 [TBL] [Abstract][Full Text] [Related]
12. Incidence and mortality of thyroid cancer in 50 countries: a joinpoint regression analysis of global trends. Huang J; Ngai CH; Deng Y; Pun CN; Lok V; Zhang L; Xu Q; Lucero-Prisno DE; Xu W; Zheng ZJ; Elcarte E; Withers M; Wong MCS; Endocrine; 2023 May; 80(2):355-365. PubMed ID: 36607509 [TBL] [Abstract][Full Text] [Related]
13. Differences in Incidence and Mortality Trends of Colorectal Cancer Worldwide Based on Sex, Age, and Anatomic Location. Wong MCS; Huang J; Lok V; Wang J; Fung F; Ding H; Zheng ZJ Clin Gastroenterol Hepatol; 2021 May; 19(5):955-966.e61. PubMed ID: 32088300 [TBL] [Abstract][Full Text] [Related]
14. Which data are available in central registries on bladder cancer patients in the five Nordic countries. Körner SK; Dreyer T; Haug ES; Jerlström T; Boström PJ; Gudjonsson S; Jensen JB Scand J Urol; 2021 Apr; 55(2):135-141. PubMed ID: 33504267 [TBL] [Abstract][Full Text] [Related]
15. Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer. Macleod LC; Yabes JG; Yu M; Fam MM; Hale NE; Turner RM; Lopa SH; Gingrich JR; Borza T; Skolarus TA; Davies BJ; Jacobs BL Urol Oncol; 2019 Jul; 37(7):462-469. PubMed ID: 31053530 [TBL] [Abstract][Full Text] [Related]
16. Increasing incidence of thyroid cancer in the Commonwealth of Pennsylvania. Bann DV; Goyal N; Camacho F; Goldenberg D JAMA Otolaryngol Head Neck Surg; 2014 Dec; 140(12):1149-56. PubMed ID: 25170647 [TBL] [Abstract][Full Text] [Related]
17. Gender- and race-specific comparison of tobacco-associated cancer incidence trends in Florida with SEER regional cancer incidence data. Lee DJ; Voti L; MacKinnon J; Koniaris LG; Fleming LE; Huang Y; Wohler B; Franceschi D; Dietz NA; Sherman R; Soler-Vilá H Cancer Causes Control; 2008 Sep; 19(7):711-23. PubMed ID: 18322816 [TBL] [Abstract][Full Text] [Related]
18. Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer. Huo J; Ray-Zack MD; Shan Y; Chamie K; Boorjian SA; Kerr P; Jana B; Freedland SJ; Kamat AM; Mehta HB; Williams SB Eur Urol Oncol; 2019 Sep; 2(5):497-504. PubMed ID: 31411998 [TBL] [Abstract][Full Text] [Related]
19. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis. Bruins HM; Aben KK; Arends TJ; van der Heijden AG; Witjes AJ Urol Oncol; 2016 Apr; 34(4):166.e1-6. PubMed ID: 26705102 [TBL] [Abstract][Full Text] [Related]
20. Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and women. Teleka S; Häggström C; Nagel G; Bjørge T; Manjer J; Ulmer H; Liedberg F; Ghaderi S; Lang A; Jonsson H; Jahnson S; Orho-Melander M; Tretli S; Stattin P; Stocks T Int J Cancer; 2018 Dec; 143(12):3071-3082. PubMed ID: 29756343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]